| 3675 |
227: Activation, PPARα |
1312: Increase, Fatty acid β-oxidation |
Oct 30, 2025 |
Oct 30, 2025 |
2 AOPs
|
| 3674 |
1005: Reduced, Swimming performance |
2382: Increase, nerve spasm |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3673 |
602: Increased, Ataxia, paralysis, or hyperactivity |
1005: Reduced, Swimming performance |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3672 |
746: Increase, Dopaminergic activity |
602: Increased, Ataxia, paralysis, or hyperactivity |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3671 |
2381: Increase, dopamine receptor gene |
746: Increase, Dopaminergic activity |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3670 |
2380: Increase, dopamine transporter gene |
746: Increase, Dopaminergic activity |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3669 |
2379: Disruption, regulatory function of dopamine signaling components. |
2381: Increase, dopamine receptor gene |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3668 |
2379: Disruption, regulatory function of dopamine signaling components. |
2380: Increase, dopamine transporter gene |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 3667 |
2108: Altered, white brain matter |
2231: Impaired locomotor function |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3666 |
386: Neuronal network function, Decreased |
2108: Altered, white brain matter |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3665 |
2378: Impaired axonal insulation |
386: Neuronal network function, Decreased |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3664 |
2266: Demyelination, increased |
2378: Impaired axonal insulation |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3663 |
2105: Decreased, mbp expression in oligodendrocytes |
2266: Demyelination, increased |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3662 |
1505: Cell cycle disruption |
2266: Demyelination, increased |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3661 |
1656: TR Antagnoism |
2105: Decreased, mbp expression in oligodendrocytes |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3660 |
1656: TR Antagnoism |
1505: Cell cycle disruption |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3659 |
2377: neural network formation |
341: Impairment, Learning and memory |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3658 |
2093: Decreased brain T4/T3 |
381: BDNF, Reduced |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3657 |
2377: neural network formation |
2231: Impaired locomotor function |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3656 |
385: Synaptogenesis, Decreased |
2377: neural network formation |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3655 |
1656: TR Antagnoism |
381: BDNF, Reduced |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3654 |
2093: Decreased brain T4/T3 |
1656: TR Antagnoism |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3653 |
1002: Inhibition, Deiodinase 2 |
2093: Decreased brain T4/T3 |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3652 |
2376: Inhibition, OATP1C1 |
2093: Decreased brain T4/T3 |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3651 |
2258: Inhibition, monocarboxylate transporter 8 (MCT8) |
2093: Decreased brain T4/T3 |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|